Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr515 Inhibitors

Olr515 inhibitors are a class of chemical compounds specifically designed to interact with and modulate the function of the olfactory receptor 515 (Olr515). These receptors belong to the larger family of G protein-coupled receptors (GPCRs), which play a crucial role in various cellular signaling pathways. Olr515, like other olfactory receptors, is primarily involved in detecting volatile molecules and contributing to the sense of smell. However, the modulation of this receptor by specific inhibitors can provide insights into its broader biological functions, as well as its role in intricate cellular networks. The inhibitors in this class are typically small molecules engineered to bind selectively to Olr515, altering its conformation and thus influencing the downstream signaling cascades initiated upon ligand binding.

The design and synthesis of Olr515 inhibitors involve a deep understanding of the receptor's structural biology and its interaction with endogenous ligands. Advanced techniques such as computational modeling, high-throughput screening, and structure-activity relationship (SAR) studies are employed to identify and refine these inhibitors. The binding affinity, selectivity, and structural properties of these inhibitors are often meticulously characterized using biochemical assays, molecular dynamics simulations, and various spectroscopic methods. Additionally, studies may focus on the conformational changes induced by these inhibitors at the molecular level, as well as their impact on the receptor's signaling efficacy and desensitization processes. By probing these molecular interactions, researchers can uncover valuable data about the dynamics of olfactory receptors and their broader implications within GPCR-related signaling pathways.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Afatinib-d4

850140-72-6 (unlabeled)sc-481821
10 mg
$4665.00
(0)

Inhibits EGFR, HER2, and HER4, potentially affecting proteins in these signaling pathways.

Bicalutamide

90357-06-5sc-202976
sc-202976A
100 mg
500 mg
$42.00
$146.00
27
(1)

Androgen receptor antagonist, potentially affecting proteins in androgen signaling pathways.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Inhibits Src family kinases, potentially influencing proteins in cell signaling pathways.

MDV3100

915087-33-1sc-364354
sc-364354A
5 mg
50 mg
$245.00
$1051.00
7
(1)

Androgen receptor inhibitor, potentially affecting proteins in androgen signaling pathways.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

Inhibits Bruton's tyrosine kinase, potentially affecting proteins in B-cell receptor signaling.

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$209.00
$413.00
9
(1)

Inhibits BCR-ABL and c-KIT tyrosine kinases, potentially affecting proteins in associated signaling pathways.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$210.00
$305.00
$495.00
10
(1)

PARP inhibitor, potentially affecting proteins involved in DNA repair pathways.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

Inhibits cyclin-dependent kinases 4 and 6, potentially affecting cell cycle-related proteins.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Inhibits multiple kinases, potentially affecting proteins in cell signaling and growth pathways.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Multi-targeted tyrosine kinase inhibitor, potentially influencing proteins involved in angiogenesis and tumor growth.